Parkinson’s Families project

Neurology questions medical concept with active human neurons shaped as a question mark as a metaphor for scientific research into the brain and neurological diseases as parkinsons alzhiemers autism dementia as part of the  nervous system anatomy.

The Parkinson’s Families Project is a new study that is being set up across the UK, led by Professor Huw Morris at the Institute of Neurology, University College London.

The aim of the study is to identify variations in genes that may cause or increase the risk of Parkinson’s. It is rare for many people in a family to be affected by Parkinson’s. The condition is passed from one generation to the next in less than 5% of cases. But as families share a common genetic background, it is easier to find new genes by studying the genetic makeup of people with Parkinson’s alongside other members of their family.

The study is looking for people who developed Parkinson’s before the age of 45 or who have a family history of Parkinson’s. Family members will also be asked to participate by donating a blood or saliva sample for DNA analysis.

By identifying genetic factors that cause Parkinson’s, we hope to understand more about the condition. The ultimate aim of this research is to develop better diagnoses, improved disease models and better treatments.

If you would like more information please contact Ms Manuela Tan on manuela.tan@nhs.net or 0207 794 0500 x 37032.

RELATED ITEMS

  • A psychological journey with Parkinson’s For me, Parkinson’s has been a strange journey which has generated some major highs and some quite extraordinary lows. Oddly, most of the lows were in my early years with the condition, even though this was a time when my symptoms were at their least…
  • Progress in Parkinson’s, both in terms of its management and improvements to its treatment, is extremely slow. There have been advances in the understanding of Parkinson’s and there is the very real possibility of therapies with the capacity to modify the course of the condition in the pipeline. However, these…
  • GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease. The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative,…
  • The research folks are gradually narrowing in on the cause of Parkinson’s — it relates to a bad-boy protein, alpha-synuclein, not properly folding and running amok with your dopamine. (“Proteins folding” always sounded like laundry to me.)  But what causes the protein to mal-fold?  Bad genes?  Something in the environment? On…
  • "Mummy, is Parkinson's contagious?" In her own way my daughter, Frida, had been interested in Parkinson's research since she was about five or six years old. And rightly so, as she was only four months old when I was diagnosed. "You have Parkinson's," the neurologist said, "Have a nice day."…